第一单位：
Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center (HUH CCC), 00029 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki (UH), 00029 Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.
作者：
Olli,Dufva [1]
;
Petri,Pölönen [2]
;
Oscar,Brück [1]
;
Mikko A I,Keränen [3]
;
Jay,Klievink [3]
;
Juha,Mehtonen [2]
;
Jani,Huuhtanen [3]
;
Ashwini,Kumar [4]
;
Disha,Malani [4]
;
Sanna,Siitonen [5]
;
Matti,Kankainen [1]
;
Bishwa,Ghimire [4]
;
Jenni,Lahtela [4]
;
Pirkko,Mattila [4]
;
Markus,Vähä-Koskela [4]
;
Krister,Wennerberg [4]
;
Kirsi,Granberg [6]
;
Suvi-Katri,Leivonen [7]
;
Leo,Meriranta [7]
;
Caroline,Heckman [8]
;
Sirpa,Leppä [9]
;
Matti,Nykter [6]
;
Olli,Lohi [10]
;
Merja,Heinäniemi [11]
;
Satu,Mustjoki [12]
作者单位：
Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center (HUH CCC), 00029 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki (UH), 00029 Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.
[1]
Institute of Biomedicine, School of Medicine, University of Eastern Finland, 70211 Kuopio, Finland.
[2]
Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center (HUH CCC), 00029 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki (UH), 00029 Helsinki, Finland.
[3]
Institute for Molecular Medicine Finland, UH, 00014 Helsinki, Finland.
[4]
Department of Clinical Chemistry, UH and HUSLAB, HUH, 00029 Helsinki, Finland.
[5]
Laboratory of Computational Biology, Faculty of Medicine and Health Technology, Tampere University (TU), 33014 Tampere, Finland.
[6]
Department of Oncology, HUH CCC, 00029 Helsinki, Finland; Applied Tumor Genomics Research Program, Faculty of Medicine, UH, 00014 Helsinki, Finland.
[7]
iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland; Institute for Molecular Medicine Finland, UH, 00014 Helsinki, Finland.
[8]
iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland; Department of Oncology, HUH CCC, 00029 Helsinki, Finland; Applied Tumor Genomics Research Program, Faculty of Medicine, UH, 00014 Helsinki, Finland.
[9]
Tampere Center for Child Health Research, TU and Tays Cancer Center, Tampere University Hospital, 33521 Tampere, Finland.
[10]
Institute of Biomedicine, School of Medicine, University of Eastern Finland, 70211 Kuopio, Finland. Electronic address: merja.heinaniemi@uef.fi.
[11]
Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center (HUH CCC), 00029 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki (UH), 00029 Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland. Electronic address: satu.mustjoki@helsinki.fi.
[12]
主题词
急性病(Acute Disease);后成说, 遗传(Epigenesis, Genetic);基因表达谱(Gene Expression Profiling);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);基因组学(Genomics);HLA抗原(HLA Antigens);人类(Humans);免疫疗法(Immunotherapy);白血病, 髓样(Leukemia, Myeloid);淋巴细胞, 肿瘤浸润(Lymphocytes, Tumor-Infiltrating);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);多发性骨髓瘤(Multiple Myeloma);突变(Mutation);肿瘤抑制蛋白质p53(Tumor Suppressor Protein p53)
DOI
10.1016/j.ccell.2020.06.002
PMID
32649887
发布时间
2021-03-08
换一批
换一批
